Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$0.28 - $1.16 $83,333 - $345,238
297,619 Added 85.03%
647,619 $213,000
Q1 2024

May 15, 2024

SELL
$1.06 - $1.67 $18,020 - $28,390
-17,000 Reduced 4.63%
350,000 $406,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $11,270 - $17,780
7,000 Added 1.94%
367,000 $664,000
Q2 2023

Aug 16, 2023

BUY
$1.14 - $1.95 $410,399 - $702,000
360,000 New
360,000 $669,000
Q2 2022

Aug 05, 2022

BUY
$2.2 - $4.2 $305,758 - $583,720
138,981 New
138,981 $331,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Coastal Bridge Advisors, LLC Portfolio

Follow Coastal Bridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.